Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for MBX Biosciences, Inc. (MBX:NASDAQ), powered by AI.
MBX Biosciences, Inc. is currently trading at $35.51. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for MBX Biosciences, Inc. on Alpha Lenz.
View MBX Biosciences, Inc.'s valuation metrics on Alpha Lenz.
“MBX Biosciences, Inc.'s ROE is -27.8%. Explore profitability and growth together.”
Ask for details →Mbx Biosciences Inc. is a biopharmaceutical company focused on the research and development of innovative endocrine therapeutics. It strives to address unmet medical needs through pioneering treatments for endocrine disorders. The company's central aim is to develop precision endocrinology therapies, leveraging proprietary technologies to create treatment options that are more precise and effective for specific patient populations. Mbx Biosciences operates at the intersection of biotechnology and healthcare, significantly impacting the health sector by working towards solutions that can transform the management of hormonal disorders. In terms of market significance, Mbx Biosciences represents the advancing frontier of personalized medicine, emphasizing targeted therapies that promise improved outcomes and quality of life for patients suffering from conditions related to hormonal imbalances. By contributing to the biopharmaceutical landscape with innovative solutions, it holds a vital role in advancing both the scientific understanding and therapeutic interventions in endocrine health.
“MBX Biosciences, Inc.'s ROE is -27.8%. Explore profitability and growth together.”
Ask for details →MBX Biosciences, Inc. (ticker: MBX) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 43 employees.
The current price is $35.51 with a P/E ratio of -x and P/B of -x.
ROE is -27.76%.